Factors Associated with Eczema Clinical Trial Awareness, Interest, and Participation in Adults.

"Conflicts of interest All authors had access to the data. The authors have no disclosures or potential conflicts of interest apart from this: ES reports personal fees from AbbVie, Amgen, Arena Pharmaceuticals, Aslan Pharma, Boston Consulting Group, Collective Acumen, LLC (CA), Dermira, Eli Lilly, Evidera, ExcerptaMedica, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Kirin Pharmaceutical Development, Leo Pharm, Medscape LLC, Merck, Pfizer, Physicians World LLC, Regeneron, Roivant, Sanofi-Genzyme, Trevi therapeutics, Valeant, WebMD. These potential conflicts of interest have been reviewed and managed by OHSU. WSB is an Advisory Board Honoraria for Incyte and Pfizer (paid to institution), receives PI research grant funding from Pfizer, and is a salaried employee of NEA. ARL and IJT are also salaried employees of NEA. Data from this manuscript were presented at the 2022 Annual American Academy of Dermatology meeting as an ePoster: “Grinich EE, Thibau IJ, Price KN, Latour E, Simpson EL, Begolka WS. 32097 Factors associated with eczema clinical trial participation in adults. J Am Acad Dermatol 2022 Sep 1; 87 (3): AB167”."

"This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors."